No: we fit the scrappier, faster end: fintech, SMB finance, independent advisors, and research-led institutional brands.
That’s a core strength. We turned Bella Private Markets into an AI-cited authority with a 200–300% AI-traffic lift.
Yes: regulated-industry discipline carries from our cannabis and healthcare work into finance claims and disclosures.
Fast: the ‘scrappier end’ is our sweet spot precisely because we can do a lot quickly when there’s runway.
We protect category position where it matters. Bella sits in institutional private-markets research; we won’t take a direct competitor in that niche. Adjacent corners of finance (fintech, SMB, advisors) we can serve in parallel without conflict.